Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02272062 · ClinicalTrials.gov registry record · NA
Patient-Reported Preferences Affecting Revascularization Decisions
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 203
- Enrollment target
NCT02272062 is a NA study that has completed, run by Duke University. The registered enrollment target is 203 participants.
The verdict
NCT02272062, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 203 participants
- Enrollment target
Study Summary
Selection of a treatment strategy for patients with symptoms due to coronary artery disease requires consideration of patient preferences. In current clinical practice, patient preferences for treatment may not be known prior to diagnostic coronary angiography. The investigators will test an internet-based shared decision-making tool which will provide education and solicit preference information prior to angiography. The investigators seek to determine if this tool can accurately assess patient preferences, and if these preferences will lead to a change in clinical management.
Interventions
- OTHER Decision-making tool for coronary artery disease treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 203 participants |
| Start Date | 2014-11 |
| Est. Completion | 2016-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02272062
The ClinicalTrials.gov registry entry for NCT02272062 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 203 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Decision-making tool for coronary artery disease treatment is the first listed.
NCT02272062 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02272062 about?
NCT02272062 is a clinical study titled "Patient-Reported Preferences Affecting Revascularization Decisions". Selection of a treatment strategy for patients with symptoms due to coronary artery disease requires consideration of patient preferences. In current clinical practice, patient preferences for treatment may not be known prior to diagnostic coronary angiography. The investigators will test an interne...
What is the current status of trial NCT02272062?
This trial is currently completed. It is a NA study. The enrollment target is 203 participants. The study started on 2014-11. Estimated completion is 2016-06.
What interventions are being tested in trial NCT02272062?
The interventions under investigation include: Decision-making tool for coronary artery disease treatment (OTHER).
Who is sponsoring clinical trial NCT02272062?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.